Canto Fitzgerald: Maintaining the Exagen (XGN.US) rating, adjusted from an increase to an increase in holdings rating, and the target price was adjusted from $5.00 to $7.00.
坎托菲茨杰拉德公司：维持Exagen(XGN.US)评级，由增持调整至增持评级, 目标价由5.00美元调整至7.00美元。
Canto Fitzgerald: Maintaining the Exagen (XGN.US) rating, adjusted from an increase to an increase in holdings rating, and the target price was adjusted from $5.00 to $7.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.